Impact on patient outcome following transfusion of bacterially contaminated platelets: The M.D. Anderson Cancer Center experience

American Journal of Clinical Pathology

Volumn 134, Issue 2, 2010, Pages 207-212

  Martínez, Fernando ^a   Tarrand, Jeffrey ^a   Lichtiger, Benjamin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Blood safety; Contaminated platelets; Transfusion microbiology

Indexed keywords

ANTIBIOTIC THERAPY; APHERESIS; ARTICLE; BACTERIUM CONTAMINATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CULTURE MEDIUM; ENTEROBACTER CLOACAE; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ROOM TEMPERATURE; STAPHYLOCOCCUS AUREUS; THROMBOCYTE TRANSFUSION;

BACTERIAL INFECTIONS; BLOOD PLATELETS; DRUG CONTAMINATION; HUMANS; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES;

EID: 77955601238     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPS9YV7YTOMRRH     Document Type: Article

References (38)

1. Strumia M, McGraw J. Frozen and dried plasma for civil and military use. JAMA. 1941;116:2378-2382.
2. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev. 2005;18:195-204.
3. Hillyer CD, Josephson CD, Blajchman MA, et al. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematology Educ Program. 2003:575-589.
4. Blajchman MA. Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang. 1998;74(suppl 2):155-159.
5. Borden CW, Hall WH. Fatal transfusion reactions from massive bacterial contamination of blood. N Engl J Med. 1951;245:760-765.
6. Braude A, Carey F, Siemienski J. Studies of bacterial transfusion reactions from refrigerated blood: the properties of cold-growing bacteria. J Clin Invest. 1955;342:311-325.
7. Reading F, Brecher M. Transfusion-related bacterial sepsis. Curr Opin Hematol. 2001;8:380-386.
8. Wagner S. Transfusion related bacterial sepsis. Curr Opin Hematol. 1997;4:464-469.
9. Goldman M, Delage G, Beauregard P, et al. A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis [letter]. Transfusion. 2002;41:1075-1076.
10. Lessa F, Leparc GF, Benson K, et al. Fatal group C streptococcal infection due to transfusion of a bacterially contaminated pooled platelet unit despite routine bacterial culture screening. Transfusion. 2008;48:2177-2183.
11. Palavecino EL, Yomtovian RA, Jacobs MR. Detecting bacterial contamination in platelet products. Clin Lab. 2006;52:443-456.
12. Arendt A, Carmean J, Koch E, et al. Fatal bacterial infections associated with platelet transfusions: United States, 2004. MMWR Morb Mortal Wkly Rep. 2005;54:168-170.
13. Eder AF, Kennedy JM, Dy BA, et al; and the American Red Cross Regional Blood Centers. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety [published online ahead of print April 28, 2009]. Transfusion. doi:10.1111/j.1537-2995.2009.02192.x.
14. Blajchman MA, Goldman M. Bacterial contamination of platelet concentrates: incidence, significance, and prevention. Semin Hematol. 2001;38(4 suppl 11):20-26.
15. Vasconcelos E, Seghatchian J. Bacterial contamination in blood components and preventative strategies: an overview. Transfus Apher Sci. 2004;31:155-163.
16. Brecher ME, Holland PV, Pineda AA, et al. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion. 2000;40:1308-1312.
17. Blajchman MA, Thornley JH, Richardson H, et al. Platelet transfusion-induced Serratia marcescens sepsis due to vacuum tube contamination. Transfusion. 1979;19:39-44.
18. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion. 1990;30:583-590.
19. Tarrand JJ, Guillot C, Wenglar M, et al. Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol. 1991;29:2245-2249.
20. Bruneau C, Perez P, Chassaigne M, et al. Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion. 2001;41:74-81.
21. Blajchman MA. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol (Basel). 2000;102:183-193.
22. Leiby DA, Kerr KL, Campos JM, et al. A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion. 1997;37:259-263.
23. Vassallo RR, Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol. 2006;13:323-330.
24. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions: a persistent problem. JAMA. 1991;266:555-558.
25. Liu HW, Yuen KY, Cheng TSY, et al. Reduction of platelet transfusion-associated sepsis by short-term bacterial culture. Vox Sang. 1999;77:1-5.
26. Muder RR, Yee YC, Rihs JD, et al. Staphylococcus epidermidis bacteremia from transfusion of contaminated platelets: application of bacterial DNA analysis. Transfusion. 1992;32:771-774.
27. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493-1499.
28. Holden F, Foley M, Devin G, et al. Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reduction. Transfusion. 2000;40:1508-1513.
29. Arnow PM, Weiss LM, Weil D, et al. Escherichia coli sepsis from contaminated platelet transfusion. Arch Intern Med. 1986;146:321-324.
30. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857-861.
31. Chiu E, Yuen KY, Lie AK, et al. A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion. 1994;34:950-954.
32. Yomtovian RA, Palavecino EL, Dysktra AH, et al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion. 2006;46:719-730.
33. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion. 2007;47:1134-1142.
34. Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang. 2008;95:13-19.
35. Benjamin RJ, Kline L, Dy BA, et al. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion. 2008;48:2348-2355.
36. Lee CK, Ho PL, Chan NK, et al. Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox Sang. 2002;83:204-208.
37. McDonald CP. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med. 2006;16:381-396.
38. de Korte D, Curvers J, de Kort WL, et al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion. 2006;46:476-485.